Suppr超能文献

澳大利亚惩教机构中丙型肝炎病毒传播的流行情况及相关风险行为。

The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities.

作者信息

Hellard M E, Hocking J S, Crofts N

机构信息

Epidemiology and Social Research Program, Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia.

出版信息

Epidemiol Infect. 2004 Jun;132(3):409-15. doi: 10.1017/s0950268803001882.

Abstract

This study measured the prevalence and the risk factors associated with HCV antibody-positive prisoners. A total of 630 prisoners completed a questionnaire about risk behaviours associated with HCV transmission and were tested for HCV antibody from a blood test. Of these 362 (57.5%) prisoners were HCV antibody positive. A total of 436 (68.8%) prisoners reported ever injecting drugs and 332 reported injecting drugs in prison. HCV-positive prisoners were more likely to have injected drugs (OR 29.9) and to have injected drugs in prison during their current incarceration (OR 3.0). Tattooing was an independent risk factor for being HCV positive (OR 2.7). This is the first study conducted on prisoners that has identified having a tattoo in prison as a risk factor for HCV. Injecting drugs whilst in prison during this incarceration was also a risk factor for HCV. Our results show prisoners who injected drugs outside of prison continue to inject in prison but in a less safe manner.

摘要

本研究测量了丙型肝炎病毒(HCV)抗体阳性囚犯的患病率及相关风险因素。共有630名囚犯完成了一份关于HCV传播相关风险行为的问卷,并接受了血液检测以检测HCV抗体。在这些囚犯中,362名(57.5%)HCV抗体呈阳性。共有436名(68.8%)囚犯报告曾注射过毒品,332名报告在监狱内注射过毒品。HCV阳性囚犯更有可能曾注射过毒品(比值比[OR]为29.9),且在当前监禁期间在监狱内注射过毒品(OR为3.0)。纹身是HCV阳性的一个独立风险因素(OR为2.7)。这是第一项针对囚犯开展的研究,该研究已确定在监狱纹身是HCV的一个风险因素。在本次监禁期间于监狱内注射毒品也是HCV的一个风险因素。我们的结果表明,在监狱外注射毒品的囚犯在监狱内仍继续注射,但方式更不安全。

相似文献

2
Tattooing in prisons--not such a pretty picture.
Am J Infect Control. 2007 Sep;35(7):477-80. doi: 10.1016/j.ajic.2006.08.002.
3
Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
Ann Epidemiol. 2018 Apr;28(4):231-235. doi: 10.1016/j.annepidem.2018.02.002. Epub 2018 Feb 10.
4
The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Aust N Z J Public Health. 2007 Feb;31(1):44-50. doi: 10.1111/j.1753-6405.2007.00009.x.
5
Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Int J Infect Dis. 2009 Mar;13(2):201-8. doi: 10.1016/j.ijid.2008.06.011. Epub 2008 Sep 13.
8
Violence and hepatitis C transmission in prison-A modified social ecological model.
PLoS One. 2020 Dec 1;15(12):e0243106. doi: 10.1371/journal.pone.0243106. eCollection 2020.

引用本文的文献

1
Hepatitis B and human immunodeficiency virus infections within correctional facilities in Ghana.
PLoS One. 2023 Nov 3;18(11):e0293009. doi: 10.1371/journal.pone.0293009. eCollection 2023.
2
Viral hepatitis in pregnancy.
J Viral Hepat. 2022 Oct;29(10):844-861. doi: 10.1111/jvh.13725. Epub 2022 Jul 7.
3
Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis.
Arch Virol. 2022 Apr;167(4):1025-1039. doi: 10.1007/s00705-022-05382-1. Epub 2022 Feb 14.
5
Viral hepatitis in correctional facilities in the Northern Territory of Australia 2003-2017.
BMC Infect Dis. 2021 Jun 16;21(1):584. doi: 10.1186/s12879-021-06286-2.
9
Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Harm Reduct J. 2018 May 11;15(1):25. doi: 10.1186/s12954-018-0230-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验